FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2941503501> ?p ?o ?g. }

• W2941503501 endingPage "2239" @default.
• W2941503501 startingPage "2233" @default.
• W2941503501 abstract "Lowering serum urate levels below the threshold for crystal formation with urate-lowering therapy (ULT) has been associated with a lower risk for gout flare reoccurrences. However, gout patients on ULT still commonly suffer from recurring gout flares. The purpose of this study was to explore prognostic factors associated with gout flare recurrence within the first 3 months, in gout patients starting ULT during an acute gout flare. Post-hoc analysis of trial data on acute gout patients randomized to either gout flare standard of care or anakinra treatment were used, including baseline demographic, laboratory, clinical, and patient-reported variables, as well as 3-month follow-up data on gout flare recurrences. Only patients starting ULT at baseline were included. Using variable selection based on clinical relevance, univariate, and multivariate binary logistic regression analyses were done to examine predictors of gout flare reoccurrence. A total of 75 patients were included in this study, of which 36 (48%) experienced a gout flare ≤ 3 months post baseline. The multivariate regression analysis revealed that CRP levels > 30 mg/L (OR 9.47) and lack of prophylaxis when starting ULT (OR 11.56) were independently associated with gout flare recurrence. Similar results were found for the univariate regression analyses. Our results show that CRP levels > 30 mg/L and lack of prophylaxis when starting ULT were prognostic factors for early gout flare reoccurrence in patients starting ULT during an acute gout flare. • Gout flare recurrences were common within the first 3 months after starting urate-lowering therapy in gout patients. • Intake of prophylaxis when starting ULT had a strong protective effect on gout flare recurrences. • C-reactive protein level > 30 mg/L was an additional prognostic factor for early (≤ 3 months) gout flare reoccurrence in patients starting ULT during an acute gout flare." @default.
• W2941503501 created "2019-05-03" @default.
• W2941503501 creator A5008395067 @default.
• W2941503501 creator A5029879973 @default.
• W2941503501 creator A5052106892 @default.
• W2941503501 creator A5086725436 @default.
• W2941503501 creator A5091151755 @default.
• W2941503501 date "2019-04-27" @default.
• W2941503501 modified "2023-10-17" @default.
• W2941503501 title "Prognostic factors associated with early gout flare recurrence in patients initiating urate-lowering therapy during an acute gout flare" @default.
• W2941503501 cites W1513940013 @default.
• W2941503501 cites W1534146221 @default.
• W2941503501 cites W1765177555 @default.
• W2941503501 cites W1964211223 @default.
• W2941503501 cites W1985749449 @default.
• W2941503501 cites W1988707456 @default.
• W2941503501 cites W1991403773 @default.
• W2941503501 cites W1998443707 @default.
• W2941503501 cites W2014787661 @default.
• W2941503501 cites W2022967311 @default.
• W2941503501 cites W2026044573 @default.
• W2941503501 cites W2030472946 @default.
• W2941503501 cites W2041929358 @default.
• W2941503501 cites W2049913374 @default.
• W2941503501 cites W2054308010 @default.
• W2941503501 cites W2054682176 @default.
• W2941503501 cites W2065974896 @default.
• W2941503501 cites W2072453475 @default.
• W2941503501 cites W2098788787 @default.
• W2941503501 cites W2114365596 @default.
• W2941503501 cites W2129259214 @default.
• W2941503501 cites W2131879291 @default.
• W2941503501 cites W2137091038 @default.
• W2941503501 cites W2138084559 @default.
• W2941503501 cites W2140964940 @default.
• W2941503501 cites W2147575954 @default.
• W2941503501 cites W2153295270 @default.
• W2941503501 cites W2171230014 @default.
• W2941503501 cites W2335302945 @default.
• W2941503501 cites W2572524540 @default.
• W2941503501 cites W2620501140 @default.
• W2941503501 cites W2768352561 @default.
• W2941503501 cites W2907058349 @default.
• W2941503501 cites W4299689471 @default.
• W2941503501 doi "https://doi.org/10.1007/s10067-019-04566-6" @default.
• W2941503501 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31030363" @default.
• W2941503501 hasPublicationYear "2019" @default.
• W2941503501 type Work @default.
• W2941503501 sameAs 2941503501 @default.
• W2941503501 citedByCount "6" @default.
• W2941503501 countsByYear W29415035012020 @default.
• W2941503501 countsByYear W29415035012022 @default.
• W2941503501 countsByYear W29415035012023 @default.
• W2941503501 crossrefType "journal-article" @default.
• W2941503501 hasAuthorship W2941503501A5008395067 @default.
• W2941503501 hasAuthorship W2941503501A5029879973 @default.
• W2941503501 hasAuthorship W2941503501A5052106892 @default.
• W2941503501 hasAuthorship W2941503501A5086725436 @default.
• W2941503501 hasAuthorship W2941503501A5091151755 @default.
• W2941503501 hasBestOaLocation W29415035011 @default.
• W2941503501 hasConcept C121332964 @default.
• W2941503501 hasConcept C126322002 @default.
• W2941503501 hasConcept C141071460 @default.
• W2941503501 hasConcept C144301174 @default.
• W2941503501 hasConcept C151956035 @default.
• W2941503501 hasConcept C198451711 @default.
• W2941503501 hasConcept C2779588948 @default.
• W2941503501 hasConcept C2779721657 @default.
• W2941503501 hasConcept C2779881121 @default.
• W2941503501 hasConcept C2780261098 @default.
• W2941503501 hasConcept C2780402116 @default.
• W2941503501 hasConcept C38180746 @default.
• W2941503501 hasConcept C44870925 @default.
• W2941503501 hasConcept C71924100 @default.
• W2941503501 hasConceptScore W2941503501C121332964 @default.
• W2941503501 hasConceptScore W2941503501C126322002 @default.
• W2941503501 hasConceptScore W2941503501C141071460 @default.
• W2941503501 hasConceptScore W2941503501C144301174 @default.
• W2941503501 hasConceptScore W2941503501C151956035 @default.
• W2941503501 hasConceptScore W2941503501C198451711 @default.
• W2941503501 hasConceptScore W2941503501C2779588948 @default.
• W2941503501 hasConceptScore W2941503501C2779721657 @default.
• W2941503501 hasConceptScore W2941503501C2779881121 @default.
• W2941503501 hasConceptScore W2941503501C2780261098 @default.
• W2941503501 hasConceptScore W2941503501C2780402116 @default.
• W2941503501 hasConceptScore W2941503501C38180746 @default.
• W2941503501 hasConceptScore W2941503501C44870925 @default.
• W2941503501 hasConceptScore W2941503501C71924100 @default.
• W2941503501 hasFunder F4320321007 @default.
• W2941503501 hasIssue "8" @default.
• W2941503501 hasLocation W29415035011 @default.
• W2941503501 hasLocation W29415035012 @default.
• W2941503501 hasLocation W29415035013 @default.
• W2941503501 hasOpenAccess W2941503501 @default.
• W2941503501 hasPrimaryLocation W29415035011 @default.
• W2941503501 hasRelatedWork W1985940900 @default.
• W2941503501 hasRelatedWork W1988026928 @default.
• W2941503501 hasRelatedWork W2347945147 @default.

• next